Phase II Trial Of Paclitaxel Plus Carboplatin In Patients With Metastatic Or Locally Advanced Collecting Duct Renal Cell Cancer
OBJECTIVES:
Primary
- Determine the response rate in patients with locally advanced or metastatic collecting
duct renal cell cancer treated with paclitaxel and carboplatin.
Secondary
- Determine the tolerability of this regimen in these patients.
OUTLINE: This is an open-label, multicenter study.
Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1.
Treatment repeats every 21 days for up to 6 courses in the absence of unacceptable toxicity
or disease progression.
Patients are followed every 3 months for 2 years and then every 6 months for 1 year.
PROJECTED ACCRUAL: A total of 14-22 patients will be accrued for this study within 4.5
years.
Interventional
Masking: Open Label, Primary Purpose: Treatment
Proportion of patients with clinical response
No
David F. McDermott, MD
Study Chair
Beth Israel Deaconess Medical Center
United States: Food and Drug Administration
CDR0000349502
NCT00077129
September 2004
Name | Location |
---|---|
CCOP - Carle Cancer Center | Urbana, Illinois 61801 |
Rush-Copley Cancer Care Center | Aurora, Illinois 60507 |
Joliet Oncology-Hematology Associates, Limited - West | Joliet, Illinois 60435 |
Carle Cancer Center at Carle Foundation Hospital | Urbana, Illinois 61801 |
Saint Anthony Memorial Health Centers | Michigan City, Indiana 46360 |
Cedar Rapids Oncology Associates | Cedar Rapids, Iowa 52403 |
Bronson Methodist Hospital | Kalamazoo, Michigan 49007 |
West Michigan Cancer Center | Kalamazoo, Michigan 49007-3731 |
Borgess Medical Center | Kalamazooaa, Michigan 49001 |
CCOP - MeritCare Hospital | Fargo, North Dakota 58122 |
St. Rita's Medical Center | Lima, Ohio 45801 |
Medical X-Ray Center, PC | Sioux Falls, South Dakota 57105 |
Avera Cancer Institute | Sioux Falls, South Dakota 57105 |
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center | La Crosse, Wisconsin 54601 |
Veterans Affairs Medical Center - Lakeside Chicago | Chicago, Illinois 60611 |
Sioux Valley Hospital and University of South Dakota Medical Center | Sioux Falls, South Dakota 57117-5134 |
St. Luke's Hospital Cancer Center | Bethlehem, Pennsylvania 18015 |
Our Lady of Mercy Medical Center Comprehensive Cancer Center | Bronx, New York 10466 |
Baptist Cancer Institute - Jacksonville | Jacksonville, Florida 32207 |
Swedish-American Regional Cancer Center | Rockford, Illinois 61104-2315 |
Robert H. Lurie Comprehensive Cancer Center at Northwestern University | Chicago, Illinois 60611 |
Hematology Oncology Associates - Skokie | Skokie, Illinois 60076 |
Swedish Covenant Hospital | Chicago, Illinois 60625 |
Mercy Hospital and Medical Center | Chicago, Illinois 60616 |
Hematology and Oncology Associates | Chicago, Illinois 60611 |
Midwest Center for Hematology/Oncology | Joliet, Illinois 60432 |
North Shore Oncology and Hematology Associates, Limited - Libertyville | Libertyville, Illinois 60048 |
Northwest Medical Specialist, PC | Niles, Illinois 60714 |
Midwest Cancer Research Group, Incorporated | Skokie, Illinois 60077 |
Hematology/Oncology of the North Shore at Gross Point Medical Center | Skokie, Illinois 60076 |
McFarland Clinic, P. C. | Ames, Iowa 50010 |
St. Luke's Hospital | Cedar Rapids, Iowa 52402 |
Mercy Regional Cancer Center at Mercy Medical Center | Cedar Rapids, Iowa 52403 |
MeritCare Clinic - Bemidji | Bemidji, Minnesota 56601 |
MeritCare Medical Group | Fargo, North Dakota 58122 |